» Articles » PMID: 35080679

Promising Bioactive Compounds from the Marine Environment and Their Potential Effects on Various Diseases

Overview
Specialty Biotechnology
Date 2022 Jan 26
PMID 35080679
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The marine environment hosts a wide variety of species that have evolved to live in harsh and challenging conditions. Marine organisms are the focus of interest due to their capacity to produce biotechnologically useful compounds. They are promising biocatalysts for new and sustainable industrial processes because of their resistance to temperature, pH, salt, and contaminants, representing an opportunity for several biotechnological applications. Encouraged by the extensive and richness of the marine environment, marine organisms' role in developing new therapeutic benefits is heading as an arable field. There is currently much interest in biologically active compounds derived from natural resources, especially compounds that can efficiently act on molecular targets, which are involved in various diseases. Studies are focused on bacteria and fungi, isolated from sediments, seawater, fish, algae, and most marine invertebrates such as sponges, mollusks, tunicates, coelenterates, and crustaceans. In addition to marine macro-organisms, such as sponges, algae, or corals, marine bacteria and fungi have been shown to produce novel secondary metabolites (SMs) with specific and intricate chemical structures that may hold the key to the production of novel drugs or leads. The marine environment is known as a rich source of chemical structures with numerous beneficial health effects. Presently, several lines of studies have provided insight into biological activities and neuroprotective effects of marine algae, including antioxidant, anti-neuroinflammatory, cholinesterase inhibitory activity, and neuronal death inhibition.

Conclusion: The application of marine-derived bioactive compounds has gained importance because of their therapeutic uses in several diseases. Marine natural products (MNPs) display various pharmaceutically significant bioactivities, including antibiotic, antiviral, neurodegenerative, anticancer, or anti-inflammatory properties. The present review focuses on the importance of critical marine bioactive compounds and their role in different diseases and highlights their possible contribution to humanity.

Citing Articles

Exploring manzamine a: a promising anti-lung cancer agent from marine sponge sp.

Su M, Zhu J, Bai L, Cao Y, Wang S Front Pharmacol. 2025; 16:1525210.

PMID: 40070571 PMC: 11893592. DOI: 10.3389/fphar.2025.1525210.


Green Nanotechnology: Naturally Sourced Nanoparticles as Antibiofilm and Antivirulence Agents Against Infectious Diseases.

Lawal H, Saeed S, Gaddafi M, Kamaruzzaman N Int J Microbiol. 2025; 2025:8746754.

PMID: 40041153 PMC: 11876540. DOI: 10.1155/ijm/8746754.


Advanced Technologies for Large Scale Supply of Marine Drugs.

Martinez H, Santos M, Pedraza L, Testera A Mar Drugs. 2025; 23(2).

PMID: 39997193 PMC: 11857447. DOI: 10.3390/md23020069.


Investigating Past, Present, and Future Trends on Interface Between Marine and Medical Research and Development: A Bibliometric Review.

Zamani M, Melnychuk T, Eisenhauer A, Gabler R, Schultz C Mar Drugs. 2025; 23(1).

PMID: 39852536 PMC: 11766621. DOI: 10.3390/md23010034.


Current antibiotics for leptospirosis: Are still effective?.

Mendu C, Rashid S, Nur Atirah Wan Mohd Azemin W, Philip N Heliyon. 2025; 11(1):e41239.

PMID: 39802004 PMC: 11720912. DOI: 10.1016/j.heliyon.2024.e41239.


References
1.
Cheung R, Wong J, Pan W, Chan Y, Yin C, Dan X . Marine lectins and their medicinal applications. Appl Microbiol Biotechnol. 2015; 99(9):3755-73. PMC: 7080081. DOI: 10.1007/s00253-015-6518-0. View

2.
Dalmaso G, Ferreira D, Vermelho A . Marine extremophiles: a source of hydrolases for biotechnological applications. Mar Drugs. 2015; 13(4):1925-65. PMC: 4413194. DOI: 10.3390/md13041925. View

3.
Molinski T, Dalisay D, Lievens S, Saludes J . Drug development from marine natural products. Nat Rev Drug Discov. 2008; 8(1):69-85. DOI: 10.1038/nrd2487. View

4.
Barbieri F, Thellung S, Wurth R, Gatto F, Corsaro A, Villa V . Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System. Int J Endocrinol. 2014; 2014:753524. PMC: 4248486. DOI: 10.1155/2014/753524. View

5.
Liu L, Xu Y, Han Z, Li Y, Lu L, Lai P . Four new antibacterial xanthones from the marine-derived actinomycetes Streptomyces caelestis. Mar Drugs. 2012; 10(11):2571-83. PMC: 3509536. DOI: 10.3390/md10112571. View